U.S. Physical Therapy (NYSE:USPH) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS

U.S. Physical Therapy (NYSE:USPH) issued its quarterly earnings data on Tuesday. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.07), Briefing.com reports. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The company had revenue of $155.70 million for the quarter, compared to analysts’ expectations of $153.30 million. During the same quarter in the prior year, the firm posted $0.59 EPS. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year.

U.S. Physical Therapy Stock Performance

NYSE:USPH traded down $2.38 during mid-day trading on Wednesday, hitting $103.21. The stock had a trading volume of 36,173 shares, compared to its average volume of 68,398. U.S. Physical Therapy has a 52 week low of $78.08 and a 52 week high of $124.11. The stock has a market capitalization of $1.56 billion, a price-to-earnings ratio of 76.52, a P/E/G ratio of 4.99 and a beta of 1.39. The company has a 50 day simple moving average of $105.26 and a 200-day simple moving average of $96.31. The company has a current ratio of 2.28, a quick ratio of 2.28 and a debt-to-equity ratio of 0.29.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, March 12th were given a $0.44 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date was Monday, March 11th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 130.37%.

Analyst Ratings Changes

Several research analysts recently issued reports on USPH shares. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. Barrington Research increased their price target on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Finally, JPMorgan Chase & Co. increased their price target on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a research report on Wednesday, March 13th. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $125.67.

Insiders Place Their Bets

In other news, EVP Richard Binstein sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $106.55, for a total value of $213,100.00. Following the transaction, the executive vice president now owns 15,006 shares of the company’s stock, valued at approximately $1,598,889.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other U.S. Physical Therapy news, Director Clayton Trier sold 400 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.00, for a total value of $42,800.00. Following the completion of the sale, the director now directly owns 7,000 shares in the company, valued at $749,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Richard Binstein sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $106.55, for a total transaction of $213,100.00. Following the completion of the sale, the executive vice president now owns 15,006 shares of the company’s stock, valued at $1,598,889.30. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,829 shares of company stock worth $1,141,535. 1.70% of the stock is owned by corporate insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.